Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetTyrosine-protein kinase Lck
LigandBDBM50120090
Substrate/Competitorn/a
Meas. Tech.ChEBML_96910
IC50 2±n/a nM
Citation Chen, PIwanowicz, EJNorris, DGu, HHLin, JMoquin, RVDas, JWityak, JSpergel, SHde Fex, HPang, SPitt, SShen, DRSchieven, GLBarrish, JC Synthesis and SAR of novel imidazoquinoxaline-based Lck inhibitors: improvement of cell potency. Bioorg Med Chem Lett12:3153-6 (2002) [PubMed]
More Info.:Get all data from this article,  Assay Method
 
Tyrosine-protein kinase Lck
Name:Tyrosine-protein kinase Lck
Synonyms:2.7.10.2 | LCK | LCK_HUMAN | LSK | Leukocyte C-terminal Src kinase | Lymphocyte cell-specific protein-tyrosine kinase | Lymphocyte-specific protein tyrosine kinase | P56-LCK | Protein YT16 | Proto-oncogene Lck | Proto-oncogene tyrosine-protein kinase LCK | Src/Lck kinase | T cell-specific protein-tyrosine kinase
Type:n/a
Mol. Mass.:57987.83
Organism:Homo sapiens (Human)
Description:P06239
Residue:509
Sequence:
MGCGCSSHPEDDWMENIDVCENCHYPIVPLDGKGTLLIRNGSEVRDPLVTYEGSNPPASP
LQDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSGEWWKAQSLTTGQEGFIPFNFVAKAN
SLEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKH
YKIRNLDNGGFYISPRITFPGLHELVRHYTNASDGLCTRLSRPCQTQKPQKPWWEDEWEV
PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL
VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY
IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK
SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER
PEDRPTFDYLRSVLEDFFTATEGQYQPQP
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM50120090
n/a
NameBDBM50120090
Synonyms:CHEMBL108686 | N*4*-(2-Chloro-6-methyl-phenyl)-N*8*,N*8*-diethyl-imidazo[1,5-a]quinoxaline-4,8-diamine | N4-(2-chloro-6-methylphenyl)-N8,N8-diethylimidazo[1,5-a]quinoxaline-4,8-diamine
TypeSmall organic molecule
Emp. Form.C21H22ClN5
Mol. Mass.379.886
SMILESCCN(CC)c1ccc2nc(Nc3c(C)cccc3Cl)c3cncn3c2c1
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: